Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program - PubMed (original) (raw)
. 2014 Apr 23;2(1):e000003.
doi: 10.1136/bmjdrc-2013-000003. eCollection 2014.
Juichi Sato 2, Kazuyo Tsushita 3, Satoru Tsujii 4, Kazuhiko Kotani 5, Makoto Tominaga 6, Shoji Kawazu 7, Yuzo Sato 8, Takeshi Usui 9, Isao Kamae 10, Toshihide Yoshida 11, Yutaka Kiyohara 12, Shigeaki Sato 13, Kokoro Tsuzaki 1, Kaoru Takahashi 14, Hideshi Kuzuya 15; Japan Diabetes Prevention Program (JDPP) Research Group
Affiliations
- PMID: 25452854
- PMCID: PMC4212559
- DOI: 10.1136/bmjdrc-2013-000003
Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program
Naoki Sakane et al. BMJ Open Diabetes Res Care. 2014.
Abstract
Objectives: To determine the effects of a lifestyle intervention on the development of type 2 diabetes mellitus (T2DM) among participants with impaired glucose tolerance (IGT), in particular in the subgroup with baseline glycated hemoglobin (HbA1c) levels ≥5.7%, in primary healthcare settings.
Design: Randomized controlled trial.
Setting: 32 healthcare centers in Japan.
Participants: Participants with IGT, aged 30-60 years, were randomly assigned to either an intensive lifestyle intervention group (ILG) or a usual care group (UCG).
Interventions: During the initial 6 months, participants in the ILG received four group sessions on healthy lifestyles by public health providers. An individual session was further conducted biannually during the 3 years. Participants in the UCG received usual care such as one group session on healthy lifestyles.
Outcome measures: The primary endpoint was the development of T2DM based on an oral glucose tolerance test.
Results: The mean follow-up period was 2.3 years. The annual incidence of T2DM were 2.7 and 5.1/100 person-years of follow-up in the ILG (n=145) and UCG (n=149), respectively. The cumulative incidence of T2DM was significantly lower in the ILG than in the UCG among participants with HbA1c levels ≥5.7% (log-rank=3.52, p=0.06; Breslow=4.05, p=0.04; Tarone-Ware=3.79, p=0.05), while this was not found among participants with HbA1c levels <5.7%.
Conclusions: Intensive lifestyle intervention in primary healthcare setting is effective in preventing the development of T2DM in IGT participants with HbA1c levels ≥5.7%, relative to those with HbA1c levels <5.7%.
Trial registration number: UMIN000003136.
Keywords: HbA1c; Impaired Glucose Tolerance; Intervention Groups; Type 2 Diabetes.
Figures
Figure 1
CONSORT flow diagram of Japan Diabetes Prevention Program (JDPP). DM, diabetes mellitus; HbA1c, glycated hemoglobin; IFG, impaired fasting glucose; NGT, normal glucose tolerance.
Figure 2
Kaplan-Meier plot of development of diabetes according to glycated hemoglobin (HbA1c) categories.
Similar articles
- Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance.
Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tsuzaki K, Tominaga M, Kawazu S, Sato Y, Usui T, Kamae I, Yoshida T, Kiyohara Y, Sato S, Kuzuya H; Japan Diabetes Prevention Program (JDPP) Research Group. Sakane N, et al. BMC Public Health. 2011 Jan 17;11(1):40. doi: 10.1186/1471-2458-11-40. BMC Public Health. 2011. PMID: 21235825 Free PMC article. Clinical Trial. - Mobile Delivery of the Diabetes Prevention Program in People With Prediabetes: Randomized Controlled Trial.
Toro-Ramos T, Michaelides A, Anton M, Karim Z, Kang-Oh L, Argyrou C, Loukaidou E, Charitou MM, Sze W, Miller JD. Toro-Ramos T, et al. JMIR Mhealth Uhealth. 2020 Jul 8;8(7):e17842. doi: 10.2196/17842. JMIR Mhealth Uhealth. 2020. PMID: 32459631 Free PMC article. Clinical Trial. - Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
Hemmingsen B, Gimenez-Perez G, Mauricio D, Roqué I Figuls M, Metzendorf MI, Richter B. Hemmingsen B, et al. Cochrane Database Syst Rev. 2017 Dec 4;12(12):CD003054. doi: 10.1002/14651858.CD003054.pub4. Cochrane Database Syst Rev. 2017. PMID: 29205264 Free PMC article. Review.
Cited by
- Dietary and other lifestyle factors and their influence on non-communicable diseases in the Western Pacific region.
Sun X, Yon DK, Nguyen TT, Tanisawa K, Son K, Zhang L, Shu J, Peng W, Yang Y, Branca F, Wahlqvist ML, Lim H, Wang Y. Sun X, et al. Lancet Reg Health West Pac. 2023 Dec 1;43:100842. doi: 10.1016/j.lanwpc.2023.100842. eCollection 2024 Feb. Lancet Reg Health West Pac. 2023. PMID: 38456094 Free PMC article. Review. - Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review.
Bodhini D, Morton RW, Santhakumar V, Nakabuye M, Pomares-Millan H, Clemmensen C, Fitzpatrick SL, Guasch-Ferre M, Pankow JS, Ried-Larsen M, Franks PW; ADA/EASD PMDI; Tobias DK, Merino J, Mohan V, Loos RJF. Bodhini D, et al. Commun Med (Lond). 2023 Oct 5;3(1):133. doi: 10.1038/s43856-023-00363-0. Commun Med (Lond). 2023. PMID: 37794109 Free PMC article. - The Effect of Lifestyle Intervention on Diabetes Prevention by Ethnicity: A Systematic Review of Intervention Characteristics Using the TIDieR Framework.
Chen M, Ukke GG, Moran LJ, Sood S, Bennett CJ, Bahri Khomami M, Absetz P, Teede H, Harrison CL, Lim S. Chen M, et al. Nutrients. 2021 Nov 17;13(11):4118. doi: 10.3390/nu13114118. Nutrients. 2021. PMID: 34836372 Free PMC article. - Obtaining evidence base for the development of Feel4Diabetes intervention to prevent type 2 diabetes - a narrative literature review.
Kivelä J, Wikström K, Virtanen E, Georgoulis M, Cardon G, Civeira F, Iotova V, Karuranga E, Ko W, Liatis S, Makrilakis K, Manios Y, Mateo-Gallego R, Nanasi A, Rurik I, Tankova T, Tsochev K, Van Stappen V, Lindström J; Feel4Diabetes research group. Kivelä J, et al. BMC Endocr Disord. 2020 Mar 12;20(Suppl 1):140. doi: 10.1186/s12902-019-0468-y. BMC Endocr Disord. 2020. PMID: 32164690 Free PMC article. Review. - Diabetes prevention in the real world: Insights from the JDPP and J-DOIT1.
Sakane N. Sakane N. J Gen Fam Med. 2017 Oct 9;18(6):325-330. doi: 10.1002/jgf2.85. eCollection 2017 Dec. J Gen Fam Med. 2017. PMID: 29264060 Free PMC article. Review.
References
- Ginter E, Simko V. Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol 2012;771:42–50 - PubMed
- Tuomilehto J, Lindström J, Eriksson JG, et al. . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344: 1343–92 - PubMed
- Kuroe A, Fukushima M, Usami M, et al. . Impaired beta-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance. Diabetes Res Clin Pract 2003;59: 71–7 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources